Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Insider Stock Trading: Carl Icahn Buys Shares of Navistar International

By

Plus, purchases at Cerulean Pharmaceuticals, Alliqua, and Nature's Sunshine Products.

PrintPRINT
Welcome to our daily roundup of top insider trades. Here's a look at the most significant inside purchases recently filed with the SEC.

Notable Purchases:
  • The billionaire activist investor Carl Icahn, a beneficial owner of commercial and military truck company Navistar International (NYSE:NAV), bought 1,027,789 shares of company stock for $34,205,404.
  • The venture capital firm Polaris Venture Management bought 1,470,582 shares of clinical-stage oncology-focused company Cerulean Pharmaceuticals (NASDAQ:CERU) for $10,294,074. Meanwhile, the major pharmaceutical company Eli Lilly (NYSE:LLY) bought 733,445 shares of company stock for $5,134,115.
  • The global biopharmaceutical company Celgene (NASDAQ:CELG) bought 714,286 shares of biomedical company Alliqua (NASDAQ:ALQA) for $5,000,002.
  • Wynnefield Partners Small Cap Value LP, a subsidiary of the value investor Wynnefield Capital, bought 23,714 shares of natural health and wellness company Nature's Sunshine Products (NASDAQ:NATR) for $313,236.
For more insider trades, see the charts below.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
BO
B
$34,205,404
2
BO
JB*
$10,294,074
3
BO
JB*
$5,134,115
4
BO
JB*
$5,000,002
5
DIR,BO
JB*
$4,800,000
6
DIR,BO
B
$1,113,747
7
CEO,CB,BO
B
$935,643
8
BO
JB*
$743,568
9
O
B
$386,220
10
BO
B
$313,236

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
CEO,DIR,BO
AS
$22,570,596
2
BO
S
$8,301,342
3
CEO,DIR
S
$2,465,944
4
CB,CEO,BO
AS
$2,104,500
5
PR
S
$2,068,454
6
CEO
S
$1,502,543
7
DIR
AS
$832,476
8
DIR
JS*,AS
$538,828
9
VP,GC,SEC
S
$448,067
10
DIR
AS
$437,130

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

An important note from Jonathan Moreland, founder of Insider Insights:

In a victory for common sense, it has been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders."

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

Jonathan Moreland is also the author of "Profit From Legal Insider Trading."
< Previous
  • 1
Next >
No positions in stocks mentioned.
PrintPRINT
 
Featured Videos

WHAT'S POPULAR IN THE VILLE